Chemical therapy medicine for treating rectum cancer

Abstract

The present invention relates to a chemotherapeutic medicine for curing rectal cancer. Said medicine is an emulsion made up by using 31250-50000 mg of 5-fluorouracil, 1250 ml of liquid paraffin wax, 500 ml of Vaseline, 500 ml of lanolin, 150 ml of Span. 350 ml of Tween ad 500 ml of liquid Chinese medicine throug a certain preparation process.

Description

technical field [0001] The invention relates to an anticancer chemotherapeutic drug, in particular to a chemotherapeutic drug for treating rectal cancer. Background technique [0002] Rectal cancer is a common malignant tumor of the digestive tract with a high incidence and a high mortality rate. The incidence of rectal cancer in my country is much higher than that in foreign countries, accounting for 60-75% of colorectal cancer, and it is more common in young and middle-aged people. In my country, rectal cancer is more common in the lower rectal cancer below the peritoneal reflexion, so the advantages of transanal clinical operation are obvious. Rectal cancer is often not detected early, so patients often lose the best time for surgery, or because it is easy to penetrate into the pelvic tissue in the early stage, the operation is difficult, and because of its low position, it is often due to consideration of the function of the anal sphincter, so the operation cannot be th...

AI Technical Summary

Problems solved by technology

[0003] At present, the widely used oral method, especially the more routinely used intravenous chemotherapy drug method is the root cause of the extremely toxic side effects and unsatisfactory curative effect of rectal cancer chemotherapy.

Regardless of intravenous or oral administration, due to the special anatomical location of rectal cancer, the amount of drug reaching the local lesion is very small, resulting in affected curative effect and relatively large side effects